TY - JOUR
T1 - Adipose‐derived stem cells and their derived microvesicles ameliorate detrusor overactivity secondary to bilateral partial iliac arterial occlusion‐induced bladder ischemia
AU - Chiang, Bing Juin
AU - Liao, Chun Hou
AU - Mao, Su Han
AU - Chien, Chiang Ting
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - (1) Background: We established a new bladder ischemia rat model through bilateral partial iliac arterial occlusion (BPAO) and investigated the therapeutic effect of adipose‐derived stem cells (ADSCs) and ADSC‐derived microvesicles (MVs); (2) Methods: The study included four groups: (1) sham, (2) BPAO, (3) BPAO + ADSCs, and (4) BPAO + ADSC‐derived MVs. Female Wistar rats with BPAO were injected with ADSCs or ADSC‐derived MVs through the femoral artery. Dop-pler flowmetry and real‐time laser speckle contrast imaging were performed to quantify blood flow in the common iliac arteries and bladder microcirculation. A 24‐h behavior study and transcysto-metrogram were conducted after 2 weeks. Bladder histology, immunostaining, and lipid peroxida-tion assay were performed. The expressions of P2X2, P2X3, M2, and M3 receptors and nerve growth factor (NGF) were evaluated; (3) Results: BPAO significantly reduced bladder microcirculation, in-tercontraction interval (ICI), and bladder volume and increased the amplitude of nonvoiding con-traction, neutrophil infiltration, and malondialdehyde and NGF levels. ADSCs and ADSC‐derived MVs significantly ameliorated these effects. The results of Western blot showed that the BPAO group exhibited the highest expression of M3 and P2X2 receptors. ADSCs significantly attenuated the expressions of M2 and P2X2 receptors. ADSC‐derived MVs significantly attenuated the expressions of M3 and P2X2 receptors; (4) Conclusions: ADSCs and ADSC‐derived MVs ameliorated the adverse effects of BPAO including bladder overactivity, bladder ischemia, and oxidative stress. In-flammation, muscarinic signaling, purinergic signaling, and NGF might be involved in the therapeutic mechanism.
AB - (1) Background: We established a new bladder ischemia rat model through bilateral partial iliac arterial occlusion (BPAO) and investigated the therapeutic effect of adipose‐derived stem cells (ADSCs) and ADSC‐derived microvesicles (MVs); (2) Methods: The study included four groups: (1) sham, (2) BPAO, (3) BPAO + ADSCs, and (4) BPAO + ADSC‐derived MVs. Female Wistar rats with BPAO were injected with ADSCs or ADSC‐derived MVs through the femoral artery. Dop-pler flowmetry and real‐time laser speckle contrast imaging were performed to quantify blood flow in the common iliac arteries and bladder microcirculation. A 24‐h behavior study and transcysto-metrogram were conducted after 2 weeks. Bladder histology, immunostaining, and lipid peroxida-tion assay were performed. The expressions of P2X2, P2X3, M2, and M3 receptors and nerve growth factor (NGF) were evaluated; (3) Results: BPAO significantly reduced bladder microcirculation, in-tercontraction interval (ICI), and bladder volume and increased the amplitude of nonvoiding con-traction, neutrophil infiltration, and malondialdehyde and NGF levels. ADSCs and ADSC‐derived MVs significantly ameliorated these effects. The results of Western blot showed that the BPAO group exhibited the highest expression of M3 and P2X2 receptors. ADSCs significantly attenuated the expressions of M2 and P2X2 receptors. ADSC‐derived MVs significantly attenuated the expressions of M3 and P2X2 receptors; (4) Conclusions: ADSCs and ADSC‐derived MVs ameliorated the adverse effects of BPAO including bladder overactivity, bladder ischemia, and oxidative stress. In-flammation, muscarinic signaling, purinergic signaling, and NGF might be involved in the therapeutic mechanism.
KW - Adipose‐derived stem cells
KW - Bilateral partial iliac arterial occlusion
KW - Bladder ischemia
KW - Detrusor overactivity
KW - Microvesicles
KW - Nerve growth factor
KW - Overactive bladder
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85108816090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108816090&partnerID=8YFLogxK
U2 - 10.3390/ijms22137000
DO - 10.3390/ijms22137000
M3 - Article
C2 - 34210091
AN - SCOPUS:85108816090
SN - 1661-6596
VL - 22
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 13
M1 - 7000
ER -